Dr Kevin King

Categories: ATMPs Focus Group
Dr Kevin King’s work with Pfizer’s global research units to ensure that our biotherapeutic molecules and vaccines are designed to have quality attributes that will meet the target product profile and the necessary physiochemical profile to enable their success in the marketplace. My industrial scientific leadership roles have focused on R&D in areas such as analytical characterization, formulation and process development. This has led to successful development of analytical, formulation and delivery technologies for a broad range of biotherapeutic modalities such as recombinant proteins, vaccines and cell and gene therapies from the discovery stage to commercial launch.
Go to Top